Patents Represented by Attorney Freddie K. Park

Find this attorney in the Justia Lawyer Directory

  • Polynucleotides for determining the pen polymorphism of human platelet membrane glycoprotein IIIa
    Patent number: 5780229
    Abstract: Isolated polynucleotide molecules and peptides encoded by these molecules can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications, relating to human platelet Pen polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from platelet mRNA, it is possible to type glycoprotein GPIIIa with regard to the Pen polymorphism, for example, in the context of diagnosing and treating clinical syndromes associated with GPIIIa-related immune responses.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 14, 1998
    Assignee: The Blood Center Research Foundation, Inc.
    Inventor: Peter J. Newman
  • Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation
    Patent number: 5616689
    Abstract: In accordance with the present invention, stabilized dispersions of collagen fibers that have been treated in order to inactivate infectious agents and methods of stabilizing such collagen fibers are provided.
    Type: Grant
    Filed: July 13, 1994
    Date of Patent: April 1, 1997
    Assignee: Collagen Corporation
    Inventors: Vivek N. Shenoy, Timothy T. Revak, George H. Chu, Hugh R. McMullin, Joel S. Rosenblatt, George R. Martin